In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia.
paper
Cited
Public
Unavailable
- Authors
- Kim, Sang-Young; Lee, Hyunseung; Kim, Hyun-Ju; Bang, Eunjung; Lee, Sung-Ho; Lee, Do-Wan; Woo, Dong-Cheol; Choi, Chi-Bong; Hong, Kwan Soo; Lee, Chulhyun; Choe, Bo-Young
- Year
- 2011
- Journal
- NMR in biomedicine
- PMID
- 21560175
- DOI
- 10.1002/nbm.1681
Subanesthetic doses of ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, impair prefrontal cortex (PFC) function in the rat and produce symptoms in humans similar to those observed in patients with schizophrenia. In the present study, in vivo (1) H-MRS and ex vivo (1) H high-resolution magic angle spinning (HR-MAS) spectroscopy was used to examine the brain metabolism of rats treated with subanesthetic doses of ketamine (30 mg/kg) for 6 days. A single voxel localization sequence (PRESS, TR/TE = 4000/20 ms and NEX=512) was used to acquire the spectra in a 30-µl voxel positioned in the cerebral cortex (including mainly PFC) of the rats (ketamine group: n=12; saline group: n=12) anesthetized with isoflurane. After the in vivo (1) H-MRS acquisition, the animals were sacrificed and the cerebral cortex tissues were extracted (ketamine group: n=7; saline group: n=7) for ex vivo (1) H HR-MAS spectroscopy (CPMG sequence, 2.0-s presaturation delay, 2.0-s acquisition time, 128 transients and 4-ms inter-pulse delay) using a 500-MHz NMR spectrometer. All proton metabolites were quantified using the LCModel. For the in vivo spectra, there was a significant increase in glutamate concentration in the cerebral cortex of the ketamine group compared with the controls (p<0.05). For the ex vivo HR-MAS spectra, there was a significant increase in the glutamate/total creatine ratio, and a decrease in the glutamine/total creatine and glutamine/glutamate ratios in the cerebral cortex tissue of the ketamine group compared with the controls. The results of the present study demonstrated that administration of subanesthetic doses of ketamine in the rat may exert at least part of their effect in the cerebral cortex by activation of glutamatergic neurotransmission.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | 2018 | 29897633 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Glutamine Metabolite Ratios are Related to Thwarted Belongingness and Perceived Burdensomeness: Preliminary Evidence from a Veteran Sample with and Without History of Suicidal Ideation. | Yancey JR et al. | — | 2025 | → |
| Microglia heterogeneity in health and disease. | Dadwal S et al. | — | 2024 | → |
| Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia. | de Bartolomeis A et al. | — | 2023 | → |
| Erbb4 Deletion From Inhibitory Interneurons Causes Psychosis-Relevant Neuroimaging Phenotypes. | Kiemes A et al. | — | 2023 | → |
| <i>Erbb4</i> deletion from fast-spiking interneurons causes psychosis-relevant neuroimaging phenotypes | Kiemes A et al. | — | 2022 | — |
| Ketamine administration in idiopathic epileptic and healthy control dogs: Can we detect differences in brain metabolite response with spectroscopy? | Wieser M et al. | — | 2022 | → |
| Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions. | Vines L et al. | — | 2022 | → |
| Niacin mitigates blood-brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor. | Ibrahim WW et al. | — | 2022 | → |
| Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine. | Silva-Cardoso GK et al. | — | 2021 | → |
| Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder. | Sarawagi A et al. | — | 2021 | → |
| Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine. | Kokkinou M et al. | — | 2021 | → |
| The potential of <sup>1</sup>H-MRS in CNS drug development. | Egerton A | — | 2021 | → |
| Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients. | Li J et al. | — | 2020 | → |
| Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial. | Milak MS et al. | — | 2020 | → |
| Gallic acid prevents ketamine-induced oxidative damages in brain regions and liver of rats. | Schimites PI et al. | — | 2020 | → |
| Ketamine effects on default mode network activity and vigilance: A randomized, placebo-controlled crossover simultaneous fMRI/EEG study. | Zacharias N et al. | — | 2020 | → |
| Serum and CSF Anti-NMDAR Antibody Testing in Psychiatry. | Warren N et al. | — | 2020 | → |
| The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research. | Langova V et al. | — | 2020 | → |
| Age-dependent effects of (+)-MK801 treatment on glutamate release and metabolism in the rat medial prefrontal cortex. | Zou Y et al. | — | 2019 | → |
| EEG findings in NMDA encephalitis - A systematic review. | Gillinder L et al. | — | 2019 | → |
| Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy. | Sekar S et al. | — | 2019 | → |
| The effects of sub-anesthetic ketamine plus ethanol on behaviors and apoptosis in the prefrontal cortex and hippocampus of adolescent rats. | Li Q et al. | — | 2019 | → |
| Astrocytes activation contributes to the antidepressant-like effect of ketamine but not scopolamine. | Wang Y et al. | — | 2018 | → |
| Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells? | Prytkova I et al. | — | 2018 | → |
| In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T. | Kim SY et al. | — | 2018 | → |
| The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. | Kokkinou M et al. | — | 2018 | → |
| Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models. | Kaebisch E et al. | — | 2017 | → |
| Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T. | Yoo CH et al. | — | 2017 | → |
| Glutamate homeostasis in the adult rat prefrontal cortex is altered by cortical docosahexaenoic acid accrual during adolescence: An in vivo<sup>1</sup>H MRS study. | McNamara RK et al. | — | 2017 | → |
| Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues. | Fitzpatrick CJ et al. | — | 2017 | → |
| Superior effects of quetiapine compared with aripiprazole and iloperidone on MK-801-induced olfactory memory impairment in female mice. | Mutlu A et al. | — | 2017 | → |
| Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia. | Ruda-Kucerova J et al. | — | 2017 | → |
| Different dosing regimens of repeated ketamine administration have opposite effects on novelty processing in rats. | Schumacher A et al. | — | 2016 | → |
| Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase. | Yamamoto T et al. | — | 2016 | → |
| Application of cross-species PET imaging to assess neurotransmitter release in brain. | Finnema SJ et al. | — | 2015 | → |
| Chronic social isolation decreases glutamate and glutamine levels and induces oxidative stress in the rat hippocampus. | Shao Y et al. | — | 2015 | → |
| Glutamate and dopamine in schizophrenia: an update for the 21st century. | Howes O et al. | — | 2015 | → |
| Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings. | Rivolta D et al. | — | 2015 | → |
| Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users. | Stone JM et al. | — | 2014 | → |
| In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T. | Napolitano A et al. | — | 2014 | → |
| Neurochemical changes observed by in vivo proton magnetic resonance spectroscopy in the mouse brain postadministration of scopolamine. | Woo DC et al. | — | 2014 | → |
| Reviewing the ketamine model for schizophrenia. | Frohlich J et al. | — | 2014 | → |
| Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use. | Freeman TP et al. | — | 2013 | → |
| Ketamine as a fast acting antidepressant: current knowledge and open questions. | Salvadore G et al. | — | 2013 | → |
| Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia. | Szulc A et al. | — | 2013 | → |
| Quantitative assessment of neurochemical changes in a rat model of long-term alcohol consumption as detected by in vivo and ex vivo proton nuclear magnetic resonance spectroscopy. | Lee DW et al. | — | 2013 | → |
| Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis. | Merritt K et al. | — | 2013 | → |
| Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study. | Nilsen LH et al. | — | 2012 | → |
| Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders. | Schaevitz LR et al. | — | 2012 | → |
| Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. | Scheidegger M et al. | — | 2012 | → |
| Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. | Stone JM et al. | — | 2012 | → |
| Preclinical (1)H-MRS neurochemical profiling in neurological and psychiatric disorders. | Lee MR et al. | — | 2012 | → |